Loading…

Administering 25-hydroxyvitamin D3 in vitamin D-deficient young type 1A diabetic patients reduces reactivity against islet autoantigens

Summary Background & aims We investigated whether improving 25-hydroxyvitamin D status in young type 1A diabetic patients reduces reactivity of peripheral blood mononuclear cells against islet autoantigens and associates with beta-cell functional changes. Methods Eight patients with 25-hydroxyvi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nutrition (Edinburgh, Scotland) Scotland), 2014-12, Vol.33 (6), p.1153-1156
Main Authors: Federico, G, Focosi, D, Marchi, B, Randazzo, E, De Donno, M, Vierucci, F, Bugliani, M, Campi, F, Scatena, F, Saggese, G, Mathieu, C, Marchetti, P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background & aims We investigated whether improving 25-hydroxyvitamin D status in young type 1A diabetic patients reduces reactivity of peripheral blood mononuclear cells against islet autoantigens and associates with beta-cell functional changes. Methods Eight patients with 25-hydroxyvitamin D deficiency (
ISSN:0261-5614
1532-1983
DOI:10.1016/j.clnu.2014.01.001